Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.

Details

Request a copyRequest a copy
Serval ID
serval:BIB_79E8BD59ECDD
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical.
Journal
Clinical microbiology and infection
Author(s)
Orasch C., Averbuch D., Mikulska M., Cordonnier C., Livermore D.M., Gyssens I.C., Klyasova G., Engelhard D., Kern W., Viscoli C., Akova M., Marchetti O.
Working group(s)
4th European Conference on Infections in Leukemia (ECIL-4), joint venture of Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation (IDWP-EBMT), Infectious Diseases Group of the European Organization for Research and Treatment of Cancer (IDG-EORTC), International Immunocompromised Host Society (ICHS), European Leukemia Net (ELN) and European Study Group on Infections in Immunocompromised Hosts of the European Society for Clinical Microbiology and Infectious Diseases (ESGICH-ESCMID)
ISSN
1469-0691 (Electronic)
ISSN-L
1198-743X
Publication state
Published
Issued date
03/2015
Peer-reviewed
Oui
Volume
21
Number
3
Pages
e25-7
Language
english
Notes
Publication types: Comment ; Letter
Publication Status: ppublish
Keywords
Anti-Bacterial Agents/therapeutic use, Female, Fever of Unknown Origin/drug therapy, Humans, Leukemia, Myeloid, Acute/complications, Male, Neutropenia/complications, Withholding Treatment/ethics
OAI-PMH
oai:serval.unil.ch:BIB_79E8BD59ECDD
DOI
10.1016/j.cmi.2014.10.014
Pubmed
25658572
Open Access
Yes
Create date
13/02/2015 9:44
Last modification date
20/08/2019 15:36
Usage data